176 related articles for article (PubMed ID: 20827193)
1. Weight loss: a neglected intervention in the management of chronic kidney disease.
Ibrahim HN; Weber ML
Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):534-8. PubMed ID: 20827193
[TBL] [Abstract][Full Text] [Related]
2. Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up.
MacLaughlin HL; Cook SA; Kariyawasam D; Roseke M; van Niekerk M; Macdougall IC
Am J Kidney Dis; 2010 Jan; 55(1):69-76. PubMed ID: 19926371
[TBL] [Abstract][Full Text] [Related]
3. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
4. Obesity and chronic kidney disease.
Eknoyan G
Nefrologia; 2011; 31(4):397-403. PubMed ID: 21623393
[TBL] [Abstract][Full Text] [Related]
5. Management of obesity-induced kidney disease: a critical review of the literature.
Kiortsis DN; Christou MA
Obes Facts; 2012; 5(6):821-32. PubMed ID: 23207569
[TBL] [Abstract][Full Text] [Related]
6. Association of obesity with inflammation in occult chronic kidney disease.
Bavbek N; Isik B; Kargili A; Uz E; Uz B; Kanbay M; Turgut F; Karakurt F; Akcay A
J Nephrol; 2008; 21(5):761-7. PubMed ID: 18949732
[TBL] [Abstract][Full Text] [Related]
7. Benefits of dietary sodium restriction in the management of chronic kidney disease.
Krikken JA; Laverman GD; Navis G
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):531-8. PubMed ID: 19713840
[TBL] [Abstract][Full Text] [Related]
8. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
Sturm G; Kollerits B; Neyer U; Ritz E; Kronenberg F;
Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
[TBL] [Abstract][Full Text] [Related]
9. Weight loss in obese patients with chronic kidney disease: who and how?
Teta D
J Ren Care; 2010 May; 36 Suppl 1():163-71. PubMed ID: 20586912
[TBL] [Abstract][Full Text] [Related]
10. Effects of weight loss on renal function in obese CKD patients: a systematic review.
Bolignano D; Zoccali C
Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv82-98. PubMed ID: 24092846
[TBL] [Abstract][Full Text] [Related]
11. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients.
Serpa Neto A; Bianco Rossi FM; Dal Moro Amarante R; Alves Buriti N; Cunha Barbosa Saheb G; Rossi M
J Nephrol; 2009; 22(5):637-46. PubMed ID: 19809997
[TBL] [Abstract][Full Text] [Related]
12. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis.
Navaneethan SD; Yehnert H; Moustarah F; Schreiber MJ; Schauer PR; Beddhu S
Clin J Am Soc Nephrol; 2009 Oct; 4(10):1565-74. PubMed ID: 19808241
[TBL] [Abstract][Full Text] [Related]
13. The impact of body weight management in chronic kidney disease patients with obesity.
Wang YL; Shu KH; Yang MF; Yang WC; Wu MJ; Lin TM; Chen CH
J Ren Nutr; 2013 Sep; 23(5):372-9. PubMed ID: 23791421
[TBL] [Abstract][Full Text] [Related]
14. [Early diagnosis of chronic kidney disease. New insights into creatinine and proteinuria].
Brandenburg V; Floege J
Med Klin (Munich); 2006 Mar; 101 Suppl 1():158-62. PubMed ID: 16802544
[TBL] [Abstract][Full Text] [Related]
15. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
16. Obesity and kidney disease: a big dilemma.
Kramer H; Luke A
Curr Opin Nephrol Hypertens; 2007 May; 16(3):237-41. PubMed ID: 17420667
[TBL] [Abstract][Full Text] [Related]
17. Effects of weight reduction regimens and bariatric surgery on chronic kidney disease in obese patients.
Abou-Mrad RM; Abu-Alfa AK; Ziyadeh FN
Am J Physiol Renal Physiol; 2013 Sep; 305(5):F613-7. PubMed ID: 23825072
[TBL] [Abstract][Full Text] [Related]
18. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
19. Renal protection with angiotensin receptor blockers: where do we stand.
Schmieder RE; Ruilope LM; Barnett AH
J Nephrol; 2011; 24(5):569-80. PubMed ID: 21404225
[TBL] [Abstract][Full Text] [Related]
20. Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases.
Bianchi S; Bigazzi R; Campese VM
Am J Kidney Dis; 2010 Apr; 55(4):671-81. PubMed ID: 20097461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
